Lexston Life Sciences Corp

Home
The Company
Contact Us
More

Lexston Life Sciences Corp

Home
The Company
Contact Us

News releases July 2022 onwards

July 4, 2022 Closing of the Private Placement (pdf)Download

News releases January to June | 2022

June 27, 2022 Private Placement increased (pdf)Download

June 15, 2022 resignation of Philippe Henry as Director and CSO (pdf)Download

June 9. 2022 Subsidiaries lay off staff (pdf)Download

June 3, 2022 Cancellation of options (pdf)Download

June 1, 2022 Private Placement (pdf)Download

May 20, 2022 Share Consolidation (pdf)Download

May 13, 2022 Share Consolidation (pdf)Download

April 11, 2022 Allenii Project (pdf)Download

March 25, 2022 appointment of CFO (pdf)Download

Jan 31, 2022 Section 56 exemption (pdf)Download

Jan 24, 2022 Egret-8SNP (pdf)Download

Jan 19, 2022 Egret-NRCirap (pdf)Download

Jan 14, 2022 Market Activity (pdf)Download

Jan 12, 2022 MOU ALVARIUS (pdf)Download

Jan 10 2022 MOU Panacea (pdf)Download

News releases | 2021

Dec 15, 2021 DTC ELIGIBILITY (pdf)Download

Nov 15, 2021 OTC listing (pdf)Download

Nov 11, 2021 Lexston NR re STOCK OPTION GRANT (pdf)Download

Sept 28, 2021 Psy (pdf)Download

Sept 23, 2021 RESEARCH and DEVELOPMENT (pdf)Download

Sept 20, 2021 ACQUISITION OF ZEN (pdf)Download

Sept 9, 2021 LEXT retains marketing consultant (pdf)Download

July 13, 2021 Section 56 update (pdf)Download

July 7, 2021 Psy PP (pdf)Download

July 5, 2021 STOCK OPTION GRANT (pdf)Download

June 30, 2021 BOD Graeme Staley (pdf)Download

June 23, 2021 initial release (pdf)Download

June 21 2021 CSE - New Listing - Lexston Life Sciences Corp_ (pdf)Download

Copyright © 2022 Lexston Life Sciences Corp - All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.